Wednesday, May 21, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Suvoda and Greenphire Announce Completion of Merger

Money Compass by Money Compass
April 24, 2025
in PR Newswire
0
Suvoda and Greenphire Announce Completion of Merger
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

CONSHOHOCKEN, Pa. and KING OF PRUSSIA, Pa., April 24, 2025 /PRNewswire/ — Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection solutions for complex, life-sustaining studies, and Greenphire, a leader in clinical trial payments, financial management, and patient support tools, today announced the successful completion of their previously announced merger, bringing the two companies under common ownership and management.

Suvoda

Through this merger, the combined company is now better equipped to provide a comprehensive solution to its customers to support the urgent and mission critical moments of their clinical trials. Its customers will have access to an expanded set of capabilities, while continuing to benefit from its steadfast commitment to high-quality services and support. The combined solutions will be unified on a powerful platform that will simplify workflows and ease the experience of running and participating in a clinical trial. The unified data layer will deliver greater insight to empower sponsors, sites, and patients to make more informed and nuanced decisions about their trials.

Related posts

Virtusa Bolsters Expansion Plans with Acquisition of Mav3rik

Virtusa Bolsters Expansion Plans with Acquisition of Mav3rik

May 20, 2025
Air Liquide partners with Manildra Group to build Australia’s largest biogenic CO₂ plant, strengthening national supply

Air Liquide partners with Manildra Group to build Australia’s largest biogenic CO₂ plant, strengthening national supply

May 20, 2025

The combined company will be known as Suvoda. Meaning “the dawn of wellbeing” in Sanskrit, Suvoda reinforces the promise to ease the patient, site, and sponsor experience in clinical trials and contribute to advancing health globally. The name Greenphire will continue at the product level.

The company will be led by Chief Executive Officer Jagath Wanninayake, Suvoda’s Founder and CEO. Thoma Bravo, a leading software investment firm, is the lead strategic investor in the combined company, with Bain Capital Tech Opportunities Fund and LLR Partners making a significant minority investment.

“We are thrilled to announce the completion of our merger and the beginning of our new journey together,” said Jagath Wanninayake, CEO of the combined company. “This partnership represents a significant milestone in our mission to optimize the financial and operational aspects of clinical trials. As one firm, we are now better able to deliver for our customers by meeting their evolving needs and providing them with enhanced solutions that will drive efficiency, reduce costs, and ultimately improve patient outcomes.”

About Suvoda
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,800 trials across 95 countries. To learn more, visit suvoda.com. Follow Suvoda on LinkedIn.

About Greenphire
Greenphire is the pioneer in financial management and patient support for global clinical trials. From participant reimbursements, travel, and engagement to study budgeting and data, site payments, and more, the company connects the dots across disparate processes and stakeholders to get studies done faster. Founded in 2008 and guided by a dedication to site and participant experience, Greenphire’s best in class solutions accommodate regional workflow preferences, navigate challenging regulatory demands, and address the unique needs of every patient. Greenphire currently supports more than one million active trial participants and more than 25,000 investigative research teams at sites in 80 countries worldwide. Greenphire Means GO. To learn more, we invite you to visit greenphire.com and follow us on LinkedIn.

Contact

Elena Filimonova
Chief Marketing Officer
[email protected]

Greenphire

Logo – https://mma.prnewswire.com/media/2671497/Greenphire_Suvoda_LLC_Logo.jpg 

Logo – https://mma.prnewswire.com/media/2671498/Greenphire.jpg

Cision View original content:https://www.prnewswire.com/apac/news-releases/suvoda-and-greenphire-announce-completion-of-merger-302436424.html

SOURCE Suvoda LLC; Greenphire

​ 

Previous Post

Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable

Next Post

Love Learning Chinese? Chinesia Launches Global Live & One-on-One Classes This May

Next Post
Love Learning Chinese? Chinesia Launches Global Live & One-on-One Classes This May

Love Learning Chinese? Chinesia Launches Global Live & One-on-One Classes This May

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • Virtusa Bolsters Expansion Plans with Acquisition of Mav3rik
  • Air Liquide partners with Manildra Group to build Australia’s largest biogenic CO₂ plant, strengthening national supply
  • Air Liquide partners with Manildra Group to build Australia’s largest biogenic CO₂ plant, strengthening national supply

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved